F11R expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.188030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.447000E-01
Normal-vs-Stage2
8.421800E-02
Normal-vs-Stage3
5.089400E-01
Normal-vs-Stage4
1.304770E-01
Stage1-vs-Stage2
3.819200E-01
Stage1-vs-Stage3
9.020800E-01
Stage1-vs-Stage4
2.859000E-01
Stage2-vs-Stage3
3.717200E-01
Stage2-vs-Stage4
3.462000E-01
Stage3-vs-Stage4
3.451600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.336600E-01
Normal-vs-AfricanAmerican
1.335160E-01
Normal-vs-Asian
1.034820E-01
Caucasian-vs-AfricanAmerican
2.906200E-01
Caucasian-vs-Asian
5.044000E-02
AfricanAmerican-vs-Asian
7.904600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.793500E-02
Normal-vs-Female
1.740990E-01
Male-vs-Female
3.804300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.086200E-01
Normal-vs-Age(41-60Yrs)
7.962300E-02
Normal-vs-Age(61-80Yrs)
1.519980E-01
Normal-vs-Age(81-100Yrs)
6.612200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.170800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.784200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.347600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.051580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.842400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.799440E-01
Normal-vs-Daily Drinker
1.563980E-01
Normal-vs-Weekly Drinker
2.299800E-01
Normal-vs-Occasional Drinker
2.538100E-02
Normal-vs-Social Drinker
1.244380E-01
Non Drinker-vs-Daily Drinker
7.539400E-01
Non Drinker-vs-Weekly Drinker
4.540800E-01
Non Drinker-vs-Occasional Drinker
1.467180E-01
Non Drinker-vs-Social Drinker
5.605800E-01
Daily Drinker-vs-Weekly Drinker
6.000600E-01
Daily Drinker-vs-Occasional Drinker
6.757700E-02
Daily Drinker-vs-Social Drinker
7.432400E-01
Weekly Drinker-vs-Occasional Drinker
3.277800E-02
Weekly Drinker-vs-Social Drinker
8.167200E-01
Occasional Drinker-vs-Social Drinker
3.577700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.37199999642002E-08
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62447832963153E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.060000E-02
Grade 1-vs-Grade 3
1.258150E-03
Grade 1-vs-Grade 4
2.37199999642002E-08
Grade 2-vs-Grade 3
2.587800E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62447832963153E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.683200E-01
Normal-vs-NonDiabetic
8.685500E-02
Diabetic-vs-NonDiabetic
1.884370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.456000E-02
Normal-vs-NoPancreatitis
1.414560E-01
Pancreatitis-vs-NoPancreatitis
7.529600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.154380E-01
Normal-vs-N1
1.063980E-01
N0-vs-N1
7.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.263000E-03
Normal-vs-TP53-NonMutant
2.841200E-01
TP53-Mutant-vs-TP53-NonMutant
3.0679000000422E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
